IBS-D vs Bile Acid Malabsorption: The Treatable Condition in 30% of IBS-D Patients
Approximately 25 to 30 percent of patients diagnosed with IBS-D actually have bile acid malabsorption. The symptoms are nearly identical: urgent watery diarrhea, cramping, and bloating. But while IBS-D treatment focuses on dietary changes and symptom management, BAM responds specifically to bile acid sequestrants with 70 to 80 percent response rates. The average time to diagnosis is over 5 years.
Current Consensus
- Systematic reviews estimate 25 to 30 percent of IBS-D patients have bile acid malabsorption on SeHCAT testing (Wedlake et al., 2009).
- Bile acid sequestrants produce symptom improvement in 70 to 80 percent of patients with confirmed BAM.
- SeHCAT is the gold standard diagnostic test but is not available in the United States; serum C4 and therapeutic trials are alternatives.
- Post-cholecystectomy diarrhea is frequently caused by Type 3 BAM and affects 10 to 20 percent of patients after gallbladder removal.
- The average diagnostic delay for BAM exceeds 5 years in most healthcare systems.
Open Questions
- Why primary (Type 2) BAM develops and whether impaired FGF19 signaling is the primary mechanism.
- When SeHCAT or an equivalent test will become available in the United States.
- Optimal dosing strategies for bile acid sequestrants across the three BAM types.
- Long-term effects of bile acid sequestrant therapy beyond 3 years.
- How often BAM and functional IBS-D coexist as genuinely separate conditions.
Not sure if this applies to you?
Our misdiagnosis quiz evaluates your symptoms against 14 conditions commonly confused with IBS.
Take the QuizArticles on Bile Acid Malabsorption and IBS
Each article includes cited sources, a medical review placeholder, and a clear distinction between what is established and what is still being studied.
Testing for Bile Acid Malabsorption When IBS Treatment Is Not Working
Practical guide to BAM testing: SeHCAT, serum C4, and therapeutic trials of cholestyramine or colesevelam. Cutoffs, dosing, what to expect, and how to interpret results.
Can Bile Acid Malabsorption Be Misdiagnosed as IBS? In 30% of Cases, Yes
BAM is the most under-tested condition in gastroenterology. Learn why 25-30% of IBS-D diagnoses may actually be bile acid malabsorption and what drives the delay.
IBS-D vs Bile Acid Malabsorption: How to Tell the Difference
Learn the key differences between IBS-D and bile acid malabsorption (BAM). Up to 30% of IBS-D patients actually have BAM, a treatable condition with specific testing.
Medical Disclaimer: The content in this section is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making changes to your health regimen. GLP1Gut is a tracking tool, not a medical device.